COVID-19 antibodies enable tissue-based detection of viral infection
HistoSure’s novel monoclonal COVID-19 antibodies developed to enable tissue-based detection of viral infection in human clinical samples have shown excellent
Read moreHistoSure’s novel monoclonal COVID-19 antibodies developed to enable tissue-based detection of viral infection in human clinical samples have shown excellent
Read moreInsilico Medicine, a Hong Kong-based pioneering biotechnology company, specialising in end-to-end artificial intelligence for target discovery, small molecule chemistry, and
Read moreGERBU manufactures high-quality NADH – β-Nicotinamide adenine dinucleotide, a reducing agent for biochemical assays. NADH reagents are utilised in enzyme
Read moreCureVac N.V, a global biopharmaceutical company creating a novel class of revolutionary medicines based on messenger ribonucleic acid (mRNA), revealed
Read moreHistoSure, in cooperation with Charles River Discovery Research Services Germany, now offers a set of groundbreaking highly validated species-specific antibodies
Read moreEvotec SE, a publicly listed drug discovery and development company headquartered in Hamburg, Germany, has launched beLAB2122, a translational $
Read moreFrench pharma giant Sanofi is set to acquire Tidal Therapeutics for $470m, adding the biotech’s novel mRNA-based research platform with
Read moreThe unique 3DProSeed® ready-to-use 96-well microtiter plate developed by Ectica Technologies contains pre-assembled synthetic hydrogels, ready for screening 3D cell
Read moreThe cutting-edge multispectral tissue cytometry hardware TissueFAXS SPECTRA, developed by TissueGnostics, has the unique ability to enable multispectral imaging of
Read moreThe modern brightfield and fluorescence scanning system by TissueGnostics offers unparalleled flexibility for researchers working on tissue-based cell culture analysis
Read more